The global neurointerventional devices market size was valued at USD 4.56 billion in 2018 and is anticipated to grow at a CAGR of 7.6% during the forecast period. Neurological devices can help diagnose, prevent, and treat a spread of neurological disorders and conditions like Alzheimer’s disease, Parkinson’s disease, major depression, epilepsy, medulla spinalis injury, and traumatic brain injury.
Key Developments in Neurointerventional Devices Market:
• In June 2018, Division of Neurological and Physical Medicine Devices (DNPMD), Center for Devices and Radiological Health (CDRH), United States Food and Drug Administration (FDA) collaborated to introduce updated regulation of neurological devices and neurointerventional endovascular approaches for Acute Ischemic Stroke.
The main manufacturing companies in the market include Johnson & Johnson, Stryker Corporation, Boston Scientific, Terumo Corporation, Karl Storz, Medtronic, Penumbra Inc., BrainLab, Elekta, and Micromar.